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Introduction
Down's syndrome (DS; trisomy 21) is the most common chromosomal disorder, affecting 1 in 1000 live births in the UK (Wu and Morris, 2013) . A common feature of DS is learning disabilities with accompanying language and memory impairments. Over recent years there has been a noticeable increase in life expectancy for adults with DS, with the median life expectancy in England and Wales currently at 58 years (Wu and Morris, 2013) . This increase in lifespan has resulted in a concomitant increase in the number of adults with DS affected by dementia, particularly Alzheimer's disease, which is considerably more prevalent in adults with DS than the general population (e.g. Zigman and Lott, 2007) . Given the increased longevity of DS patients, it has become increasingly important to understand the underlying changes that occur with age and dementia in this condition.
Research into mnemonic impairments in DS has typically focused on medial temporal lobe structures, which are smaller in DS patients even when overall brain size is taken into account (Carducci et al., 2013; Kemper 1991; Krasuski et al., 2002; Pinter et al., 2001) . However, there is an increasing realisation that it is necessary to look beyond the hippocampal formation in conditions that present with memory impairments. In doing so, the anterior thalamic nuclei (ATN) become an obvious target due to their connections with the hippocampal formation and their importance for memory (Dillingham et al., 2015; Harding et al., 2000; Jankowski et al., 2013; Van der Werf et al., 2003; Wolff and Vann, in press ). The presence of neurofibrillary tangles and plaques in the ATN of patients with Alzheimer's disease further highlights the potential relevance of this structure to DS (Aggleton et al., 2016; Braak and Braak, 1991a; Rub et al., 2016) . Despite these potential links, there is very little currently known about the status of the ATN in patients with DS. Neuroimaging studies have only focused on the thalamus as a whole (e.g. Annus et al., 2017; Teipel et al., 2004) , which does not take into account the structural and functional heterogeneity with the thalamus. Due to their size and location, it is difficult to obtain accurate measures of ATN volume using current neuroimaging techniques, which makes post-mortem assessments all the more important.
Moreover, post-mortem tissue enables assessments at the cellular level in addition to volumetric measures. Therefore, stereological counts of neurons and glial cells were made in the ATN of four aged female brains with DS and six age-matched controls.
Method

Patient characteristics
Brains from four female Down's syndrome (DS) patients (mean age 69, range, 61 -80) were provided by the Netherlands Brain Bank and six female age-matched controls (mean age 71; range 60 -85) were obtained post-mortem according to Danish law regarding the use of autopsied human tissue in research. The diagnosis of DS was based on the characteristic physical appearance of patients and presence of intellectual disability as post-mortem chromosomal analysis was not available (see Table 1 for clinical data).
Patient 1 was first noted as having seizures at the age of 36 with an EEG showing mild diffuse cerebral disorder with focal abnormalities in both temporal regions; the patient was treated with anti-epileptic medication. When she was 53, Patient 1 had been free from seizures for many years but started showing the first symptoms of dementia. Two years following the onset of dementia symptoms, she was admitted to a nursing home where she gradually deteriorated both mentally and physically. A year prior to death she suffered from several epileptic seizures. The post-mortem
Stage 3 and Stage 4 Alzheimer's disease and she started to have minor epileptic insults. EEG showed a diffuse abnormality. According to the post-mortem neuropathology report the brain was severely atrophied with numerous plaques and tangles across all lobes and in the hippocampus. The pons, putamen, medulla oblongata, and cerebellum showed no abnormality.
Patient 3 was diagnosed with epilepsy at the age of 26. An EEG carried out when the patient was 37
showed diffuse irregular activity. She was admitted into a home at the age of 44. At the age of 60 the patient had a marked decrease in general functioning with the likely diagnosis Alzheimer's disease and at 64 she was thought to have Stage 2 Alzheimer's disease. A report from the following year stated that she was unable to differentiate between members of her family and nursing home staff and she was disoriented in time and place with difficulties in communication. In the last two months before death a cognitive assessment showed her linguistic and communicative skills to be severely disturbed as were her memory function, orientation and concentration. The post-mortem neuropathological report identified numerous tangles and plaques in the cortex, hippocampus and amygdala. The cingulate gyrus showed severe spongiosis while the medulla oblongata, cervical medulla, and cerebellum showed no abnormalities.
Patient 4 was admitted to a nursing home at the age of 66 due to a diagnosis of dementia. However, the patient remained alert until her death and continued to recognise people and make demands.
An EEG carried out when the patient was 70 showed decreased alpha rhythm and an epileptic predisposition although clinically there was no indication of epilepsy. The neuropathology report detailed numerous plaques and tangles across the cortex and hippocampus. The substantia nigra, cingulate gyrus, locus coeruleus, pons and cerebellum showed no abnormalities. `The amygdala
showed only a few neurofibrillary tangles and senile plaques.
Tissue Processing
Brains were fixed with 0.1M sodium phosphate buffered 4% formaldehyde (pH 7.2) for a mean of 8 years for DS brains (range 7 -9 years) and 15 years for control brains (range 3 -22 years). The cerebrum was detached at the level of the third cranial nerve, the meninges were removed and hemispheres were processed as previously described (Karlsen and Pakkenberg, 2011) . Coronal sections 40µm thick were stained with Giemsa's azur eosin methylene blue solution (Merck, Darmstadt, Germany) and KHPO4 (pH 4.5) in a 1:4 ratio. Slides were coded by a researcher not involved in data collection to allow blinded analyses. Although there were variations in fixation time,
there was no obvious difference in tissue quality or counting conditions. Furthermore, length of time in fixative did not correlate with any measure (lowest P c = 0.13).
Cell number and volume estimation
Due to the difficulty in distinguishing between the anteromedial and anteroventral thalamic nuclei in Nissl-stained human tissue, these nuclei were grouped together as the anterior principal nuclei (APn; Fig. 1A -E) and delineated as previously described (Armstrong, 1990; Harding et al., 2000; Hirai et al., 1989 ). The APn is predominantly encapsulated by fibres making it easily identifiable; only the inferior edge of the structure does not have a clear boundary. The APn was distinguishable from the anterodorsal, parataenial, and paraventricular thalamic nuclei by laminae that encapsulate these nuclei. There was a maximum of one section per brain where the central medial thalamic nuclei
were not as distinct from the ventral medial tip of the APn. For these sections, where possible, the lamina separating the paraventricular and central medial thalamic nuclei from the APn was used as a guide for distinguishing the ventral medial portion.
The number of neurons and glial cells were estimated from one hemisphere per brain using the optical fractionator method (Gundersen, 1986; West et al., 1991) . Slides were mounted on an
Olympus BX60 microscope equipped with a computer driven X -Y motorised stage (ProScan III Prior, UK) with Z-axis focus control (Heidenhain Encoder, Germany) and a CMOS camera (Basler, Germany) M A N U S C R I P T
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connected to a computer running the NewCast Stereology software package (Visiopharm, Hørsholm, Denmark). Differentiation of neuron and glial cell types was based on cell morphology as previously described (Karlsen and Pakkenberg, 2011; Pelvig et al., 2008) . In brief, neurons have a single large nucleolus and a large nucleus surrounded by a visible cytoplasm. Neurons can be further classified into 'small' local inhibitory neurons and 'large' projecting excitatory neurons based on size (Armstrong, 1990; Dorph-Petersen et al., 2004) . As shown in Fig , 2004) . These two types of neurons are only referred to as small and large in this study as all cell volumes were biased at least to some degree due to paraffin as embedding media and should be evaluated in that light. Oligodendrocytes were identified as having a small rounded nucleus with dense chromatin and a perinuclear halo (Fig. 1F ). Astrocytes have a pale nucleus surrounded by a translucent cytoplasm and heterochromatin concentrated in granules in a rim below the nuclear membrane. Microglia appear small and elongated or comma shaped with dense peripheral chromatin. The nucleus was the counting item for both neurons and glial cells during sampling.
Sampling of sections followed a systematic, uniform random sampling scheme to ensure all parts of the APn had an equal chance of being sampled. A section sampling fraction of 1/16 was employed resulting in 9 -15 sections sampled per brain (mounted section thickness 40 µm). The contour of the APn was traced live using a 10x objective (0.4 NA) and cells were counted using a 100x oil immersion objective (NA 1.35) with a final onscreen magnification of 3000x. A disector height of 20µm with a 5µm guard zone was used to sample in the z-axis. The counting frame area was 2800 µm 2 for neurons and 1350 µm 2 for glial cells. The x -y step length was adjusted to allow optimal sampling of brains considered 'large' and 'small' but did not change within cases. The x -y step length was set to 400 -1000 µm 2 for neurons and 800 -1000 µm 2 for glial cells. These sampling 
where ssf is the section sampling fraction; the area sampling fraction (asf), is the ratio of the counting frame area to the area of the x -y step length; the height sampling fraction (hsf), is the ratio of the disector probe height to the Q -weighted tissue thickness; and ∑ Q -is the total count of cells sampled (Dorph-Petersen et al., 2004) . The density of neurons and glia was calculated as N/volume.
The unilateral volume of the APn was estimated according to Cavaleri's principle (Gundersen and Jensen, 1987; Gundersen et al., 1999) but was not corrected for tissue shrinkage as the degree of shrinkage between control and DS brains was estimated to be the same in a previous study using the same samples (Karlsen and Pakkenberg, 2011) .
The coefficient of error (CE) was calculated as (Gundersen et al., 1999) to provide information regarding the precision of the estimates. The CE for group estimates of each measure was estimated as:
where CE x is the mean CE estimate and n is the number of individuals. As a measure of the variability of the estimates the observed inter-individual coefficient of variation (CV = standard deviation/mean) are reported in parentheses after group means in Fig. 3 .
To provide an indication of the amyloid plaque burden within the APn, 1 -2 midsections from DS brains were available for amyloid-ß (Aß) immunohistochemical staining (M0872, 1:1000,
DAKO, Denmark). Applying an adapted point-counting method (Madsen et al., 2018) , we estimated the volume fraction percentage of Aß by overlaying a grid with 100 points spaced equally 115 µm apart ( Fig. 2) with a final on-screen magnification of 220x. The number of grid-points hitting the Aß plaques and tissue were counted to provide the area fraction of the amyloid plaque burden to tissue.
Statistics
Differences between groups were tested using an independent means t-test (two-tailed). Welch's ttest for unequal variances was used where appropriate. A Mann-Whitney U test was used when normality tests failed. Where relevant, effect sizes between groups were expressed as Hedges g when equal variances were assumed, Glass's Δ when equal variances were not assumed, or η 2 following a Mann-Whitney U test (Fritz et al., 2012) . The common language effect size (CL), the percentage of occasions that a randomly sampled case from distribution with the higher mean will have a higher score compared to a randomly sampled case from the distribution with the lower mean (Lakens, 2013; McGraw and Wong, 1992) , is also reported for the key measures total neurons, total glial cells, and volume to conceptualise the size of these effects. Pearson's correlation was used to assess relationships between variables. SPSS software (version 20, IBM Corporation) was used to carry out statistical analyses. The Holm-Bonferroni procedure was used to correct for multiple comparisons. The corrected P-values (P c ) of less than 0.05 were considered significant.
The CE estimates for the total number of neurons was 0.07 for both control and DS brains, for large neurons it was 0.09 for both groups, and for small neurons it was 0.14 for control and 0.11 for DS brains. The CE estimates for total glial cells was 0.04 for both control and DS brains, for oligodendrocytes it was 0.07 for control and 0.08 for DS brains, for astroglia it was 0.05 for both groups, and for microglia it was 0.51 for controls and 0.49 for DS brains. Estimates of final CE for volume was 0.05 both control and DS brains.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Results
As shown in Fig. 3 , there was a 68% reduction in total numbers of neurons in the APn of the Down's syndrome (DS) brains compared to controls. This difference was found to be significant (t(7.98) = 6.99, P c < .001; Δ = 3.68, 95% CI 1.67 -5.81, CL = 99%; Fig. 3A ). This overall reduction reflected changes in both large (t(8) = 5.26, P c < 0.01; g = 3.06, 95% CI 1.22 -4.91; Fig. 3B ) and small neurons (Mann-Whitney U = 0.00, P c = 0.029; η 2 = 0.65; Fig. 2C ).
There was a significant 37% reduction in estimated total number of glial cells in DS brains compared to controls (t(8) = 3.43, P c = 0.036; g = 2.00, 95% CI 1.48 -5.43, CL = 93%; Fig. 3D ). A significant reduction in DS brains was also observed when glial cells were classified as astroglia (t (8) = 3.58, P c = 0.036; g = 2.09, 95% CI 0.53 -3.65; Fig. 3E ). The difference for oligodendrocytes was borderline significant when corrected (t(8) = 2.73 P c = 0.052, P = 0.026; g = 1.59, 95% CI 0.14 -3.03; Fig. 3F ).
The estimated volume of the APn was 62% less in DS brains than controls and this reduction was significant (t(7.99) = 10.09, P c < .001; Δ = 5.27, 95% CI 2.70 -8.05, CL = 99%; Fig. 3G ). The estimated density of total neurons for DS brains did not differ from the estimate for controls (t(8) =
1.33, P = 0.22; Fig. 3H ). However, the estimated total glial cell density in DS brains was significantly higher than the estimate in controls, (t(8) = 4.12, P c = 0.02; g = 2.40, 95% CI 0.76 -4.05; Fig. 3I ). For microglia, the number available for sampling was consistently low (2 -20 per brain), resulting in high group CE values (0.49 -0.51). Controls were estimated to have 1.64 x 10 6 (CV, 0.93) microglia whereas DS brains had 0.94 x 10 6 (CV, 0.51) microglia, although this reduction was not significant (P > 0.40).
The area fraction of the APn occupied by Aß in DS brains had a mean estimate of 7.5%
(range, 6 -9%; CV, 0.17). Although no significant correlations between Aß and each measure were found there was a trend of fewer total neurons (r = -0.62, P c > 0.40) and a greater number of total glial cells (r = 0.84, P c > 0.40) with increased Aß burden in the APn.
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Discussion
We estimated the total number of neurons and glial cells in the combined anteroventral and anteromedial thalamic nuclei (anterior principal thalamic nuclei, APn) of aged women with Down's syndrome (DS). When compared to age-matched controls, there were striking changes with almost 70% fewer neurons in the DS brains, with reductions in both large and small neurons. Glial cells were also reduced but to a lesser degree (37%), with comparable changes across astrocytes and oligodendrocytes. The overall volume of APn was also markedly reduced (62%) in DS patients. As a result, there was no difference in neuronal density between DS patients and controls. A similar pattern is found in Korsakoff patients whereby neuron density is unaffected but overall numbers are reduced by ~50% (Harding et al., 2000) highlighting the importance of assessing overall cell counts and not just neuronal density.
While the current study focused on the APn, previous studies using the same brains have reported changes in the mediodorsal thalamic nucleus and cortical regions (Karlsen et al., 2014; Karlsen and Pakkenberg, 2011) . While the volume of the mediodorsal thalamic nucleus was reduced to a similar extent as the APn (59%), the overall cell loss was less with a 43% reduction in neurons but no changes in glial cells (Karlsen et al., 2014) . This highlights the limitations of treating the thalamus as a unitary structure. Furthermore, it becomes clear that simple volumetric measures can mask substantial variations in patterns of cell loss. Compared to the cortex, there were greater reductions in the APn when considering both volume and neuronal count reduction (i.e. ~40% for both in cortex; Karlsen and Pakkenberg, 2011) . In contrast, the reduction in neocortical glial cells was more comparable to the current findings (i.e. ~30%; Karlsen and Pakkenberg, 2011) . Together, the changes found in APn are more pronounced than other areas assessed in the same brains, particularly when considering the reduction in neurons.
While there are some differences between the patient and control groups in terms of the cause of death, post-mortem interval and length of time in fixative (see Table 1 ), the present M A N U S C R I P T
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12 findings are unlikely to be due to these factors (Blair et al., 2016) . The basal ganglia were also examined in these same brains and there was no neuronal loss in this structure (Karlsen and Pakkenberg, 2011) , confirming the specificity of the current findings.
An obvious consideration is the extent to which these APn changes simply reflect the accompanying dementia in this patient group rather than being directly related to DS, especially given the finding that neuronal numbers within some thalamic nuclei have been shown to correlate with amyloid (Erskine et al., 2016; Erskine et al., 2017) . Pathology related to Alzheimer's disease (AD) is a common feature in DS patients with the onset of amyloid pathology commencing as early as the late teens and dementia often occurring by the mid-50s (Davidson et al., 2018; Head et al., 2012) .
Across the cortex and hippocampal formation, the development patterns of neurofibrillary tangles are comparable across DS and AD groups although there appears to be more widespread and denser deposition of amyloid plaques in DS (Hof et al., 1995) . However, Braak found no noticeable difference in AD-related pathology in the anterior thalamus of AD patients with or without DS (Braak and Braak, 1991a ). There are surprisingly few studies that have quantitatively assessed the anterior thalamic nuclei (ATN) in AD (without accompanying DS) and even fewer that have carried out neuronal counts. While tangles and plaques are present in the APn, it is the anterodorsal thalamic nucleus that is most severely affected (Braak and Braak, 1991a; Rub et al., 2016; Xuereb et al., 1991) .
Consistent with this, Xuereb et al. (1991) found no significant reduction in either volume or neuronal counts in the APn of AD patients, although there was a significant reduction in neuronal counts in the anterodorsal nucleus. Similarly, Hornberger et al. (2012) found no significant reduction in ATN volume in AD patients using either neuroimaging or post-mortem tissue. Given the small cohort, it is difficult to draw conclusions regarding AD pathology in the current study. Two of the patients were categorised as Braak stage 5 and two as Braak stage 6, which relates to the extent of neurofibrillary pathology in the brain. These are both considered late stages of AD with abnormal tau pathology extending into the non-limbic cortical areas (Braak et al., 2006) . There is no clear relationship between Braak stage of neurofibrillary tangles and APn volume or neuronal density from the current M A N U S C R I P T
13 data. In contrast, the number of glia cells in the stage 6 patients seems higher than those in stage 5 patients, especially when considering oligodendrocytes. All patients appeared to have the most severe Braak staging of amyloid (i.e., "c"), where amyloid deposits are found across cortical areas (Braak and Braak, 1991b) . Accordingly, our semi-quantitative analysis of amyloid protein found high levels in the APn in the current patients with a (non-significant) trend of fewer neurons and a greater number of glial cells with a greater amyloid presence. Taken together, the APn pathology we report here does not seem to mirror what is found in standard AD, but the earlier onset of AD-like pathology in DS and the greater presence of amyloid plaques may exacerbate the cell loss.
Surprisingly, the current findings show greater similarity to other dementias such as the semantic variant of primary progressive aphasia and fronto-temporal dementia where there is ~30-40% decrease in ATN volume (Tan et al., 2014) .
The current findings raise the question as to whether ATN pathology is a common feature of DS and whether the ATN are also compromised in younger patients with DS. At present, very little is known about the status of the ATN in this patient group. Studies in younger patients have typically only measured the thalamus as a whole and in doing so have not found any difference between patient and control groups (Annus et al., 2017 ; but see Gunbey et al., 2017; Jernigan et al., 1993; Weis et al., 1991) . However, this approach may be masking more selective changes within the ATN.
Reports of enlarged 3 rd ventricles in younger DS patients could also be indicative of atrophy within the ATN (Raz et al., 1995; Schimmel et al., 2006) . Consistent with this, the mammillary bodies were shown to be markedly smaller in adults with DS, moreover, their size significantly correlated with general aptitude (Raz et al., 1995) . Given the reductions in mammillary body and hippocampal volume, and the dense connectivity between these structures and the ATN (Bubb et al., 2017) , it is possible that the ATN are also compromised at an earlier time-point in DS patients. Pathology within the extended hippocampal-diencephalic network would be consistent with the pattern of memory impairments observed in DS, where there is greater disruption to explicit compared to implicit M A N U S C R I P T
14 memory (Vicari et al., 2000) . A similar memory profile is found following damage to the mammillary body-thalamic axis (Carlesimo et al., 2007; Tsivilis et al., 2008; Vann et al., 2009) .
A limitation of the study is the small sample size, as is often the case with post-mortem studies. However, the pattern of cell loss in all DS brains was very consistent, both in the APn as well as previous structures measured (Karlsen et al., 2014; Karlsen and Pakkenberg, 2011) . Furthermore, although we had a low sample size, the differences found on key measures was reliable, with large effect sizes. The sample size was, therefore, sufficient to detect the differences reported, although there are clear limitations in the correlative inferences that can be made. Small sample sizes can also produce erroneous effects due to incomplete sampling of the population; again the consistency in findings across various measures makes this less likely to be the case in the current study. There was also limited information available regarding pre-mortem cognitive status although from the information available the least cognitively impaired patient (Patient 4) had the greatest number of APn neurons.
Together, these data show a striking decrease in both the volume and cell number of APn in aged DS patients. The pathology in this region is likely to contribute to memory impairments given the importance of this region for mnemonic processes. These findings re-enforce the need to look beyond the medial temporal lobe when considering neurological conditions that present with memory impairments. There is also a clear need to further assess this structure in future studies of DS to determine the age of onset of ATN pathology in this patient group.
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